Milestone Pharmaceuticals Inc. (MIST)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:18AM EDT. Market open.
| Previous Close | 1.7000 |
| Open | 1.7100 |
| Bid | 1.6300 x 100 |
| Ask | 1.7300 x 100 |
| Day's Range | 1.6400 - 1.7100 |
| 52 Week Range | 1.3300 - 4.4900 |
| Volume | |
| Avg. Volume | 323,677 |
| Market Cap | 88.835M |
| Beta (5Y Monthly) | 1.77 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Down -43.64% in 4 Weeks, Here's Why Milestone Pharmaceuticals (MIST) Looks Ripe for a Turnaround
Milestone Pharmaceuticals (MIST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Zacks
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
Milestone Pharma (MIST) plunges 31% following an RTF letter from the FDA due to insufficient data to begin a substantive review of the regulatory filing for etripamil nasal spray to treat PSVT.
- Simply Wall St.
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) top owners are individual investors with 52% stake, while 34% is held by institutions
Key Insights Significant control over Milestone Pharmaceuticals by individual investors implies that the general public...
© 2024 Yahoo. All rights reserved.